Marimed (MRMD) Profit After Tax Growth (1y) (2012 - 2026)
Marimed (MRMD) Profit After Tax Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -303.53% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.27% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 34.32% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | -157.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -157.28% |
| Mar 31, 2026 | 30.92% |
| Dec 31, 2025 | 44.09% |
| Sep 30, 2025 | -193.04% |
| Jun 30, 2025 | 21.59% |
| Mar 31, 2025 | -292.20% |
| Dec 31, 2024 | 18.37% |
| Sep 30, 2024 | 76.38% |
| Jun 30, 2024 | -90.27% |
| Mar 31, 2024 | -110.39% |
| Dec 31, 2023 | -320.63% |
| Sep 30, 2023 | -257.39% |
| Jun 30, 2023 | -149.31% |
| Mar 31, 2023 | -115.66% |
| Dec 31, 2022 | 175.45% |
| Sep 30, 2022 | 27.46% |
| Jun 30, 2022 | -75.02% |
| Mar 31, 2022 | 0.50% |
| Dec 31, 2021 | -238.66% |
| Sep 30, 2021 | 25.19% |